ID: ALA4762668

Max Phase: Preclinical

Molecular Formula: C35H42F3N7O7

Molecular Weight: 615.74

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(=O)NCCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C33H41N7O5.C2HF3O2/c1-23(41)35-20-9-21-37-33(45)40-32(34)36-19-8-14-28(30(43)38-22-24-15-17-27(42)18-16-24)39-31(44)29(25-10-4-2-5-11-25)26-12-6-3-7-13-26;3-2(4,5)1(6)7/h2-7,10-13,15-18,28-29,42H,8-9,14,19-22H2,1H3,(H,35,41)(H,38,43)(H,39,44)(H4,34,36,37,40,45);(H,6,7)/t28-;/m1./s1

Standard InChI Key:  QDSXZCXLJXFHQJ-LNLSOMNWSA-N

Associated Targets(Human)

Neuropeptide Y receptor type 1 5019 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 615.74Molecular Weight (Monoisotopic): 615.3169AlogP: 2.25#Rotatable Bonds: 15
Polar Surface Area: 187.04Molecular Species: BASEHBA: 5HBD: 7
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.49CX Basic pKa: 9.08CX LogP: 0.86CX LogD: -0.29
Aromatic Rings: 3Heavy Atoms: 45QED Weighted: 0.08Np Likeness Score: -0.30

References

1. Buschmann, Jonas, Seiler, Theresa, Bernhardt, Gunther, Keller, Max, Wifling, David.  (2020)  Argininamide-type neuropeptide Y Y1 receptor antagonists: the nature of Nomega-carbamoyl substituents determines Y1R binding mode and affinity,  11  (2): [PMID:33479634] [10.1039/c9md00538b]

Source